# Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

> **NCT04591808** · PHASE3 · TERMINATED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 146 (actual)

## Conditions studied

- Dyslipidemias
- Hypertension

## Interventions

- **DRUG:** Atorvastatin/Perindopril
- **DRUG:** Atorvastatin
- **DRUG:** Perindopril

## Key facts

- **NCT ID:** NCT04591808
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-09
- **Primary completion:** 2022-04-08
- **Final completion:** 2022-04-08
- **Target enrollment:** 146 (ACTUAL)
- **Why stopped:** for strategic reasons
- **Last updated:** 2023-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591808, "Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04591808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*